Xuguang Song

Phase II trial of co‐administration of CD19‐ and CD20‐targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma

Wei Sang, Ming Shi, Jing‐Jing Yang et al. · Cancer Medicine · 2020 · 78 citations · Full text

Medicine, Hematology, Oncology +16

Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma

Wei Sang, Xiangmin Wang, Hongzhi Geng et al. · Frontiers in Immunology · 2022 · 64 citations · Full text

Life Sciences, Immunology, Oncology +17

Cdc42 inhibitor ML141 enhances G-CSF-induced hematopoietic stem and progenitor cell mobilization

Chong Chen, Xuguang Song, Sha Ma et al. · International Journal of Hematology · 2014 · 22 citations

Life Sciences, Cell Biology, Hematology +15

Kinetics of immune reconstitution after anti‐CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients

Ying Wang, Hujun Li, Xuguang Song et al. · International Journal of Laboratory Hematology · 2020 · 21 citations

Life Sciences, Hematology, Immunology +17

The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation

Kai Zhao, Dongmei Zhao, Dong Huang et al. · Immunobiology · 2013 · 20 citations

Life Sciences, Hematology, Immunology +14